The Drug-Induced Respiratory Disease Website
Acute/chronic. Due to the high background incidence rate of naturally-occurring VTE, a cause-and-effect relationship with drugs or procedures may be difficult to establish firmly. Epidemiologic studies can be supportive (PMID 25924683). A search for antiphospholipid antibodies is indicated. Chronic iatrogenic thromboembolism, for instance in patients with cardiac wires and leads may cause thromboembolic pulmonary hypertension (PMID 24881082)
Publications
Testosterone replacement therapy and the risk of venous thromboembolism: A systematic review and meta-analysis of randomized controlled trials.
Thrombosis research 2021 03;199;123-131 — 2021 03 — 123-131
Thromboembolism peaking 3 months after starting testosterone therapy: testosterone-thrombophilia interactions.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2018 Apr;66;733-738 — 2018 Apr — 733-738
Pulmonary Embolism Secondary to Testosterone-Enhancing Herbal Supplement Use.
Cureus 2017 Aug 06;9;e1545 — 2017 Aug 06 — e1545
Thrombophilia in 67 Patients With Thrombotic Events After Starting Testosterone Therapy.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2016 Sep;22;548-53 — 2016 Sep — 548-53